Mangoceuticals, Inc. entered into a Subscription Agreement on June 29, 2026, with an accredited investor for the private placement of 850,000 shares of restricted common stock. The investor paid $0.32 per share, totaling $272,000 in gross proceeds. The agreement includes piggyback registration rights for one year following the subscription date. Mangoceuticals, Inc. is a pharmaceutical company.
